Rheumatology Network's Top 5: May 7, 2022


Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending May 7, 2022.

Rheumatoid Arthritis Quiz: Maximizing the Benefits of at Treat-to-Target Strategy

The American College of Rheumatology recommends that a treat-to-target strategy is followed for rheumatoid arthritis. Test your knowledge of how to maximize the potential benefits of this approach with this quiz.

Q&A: Long-Term Safety of Ixekizumab Use in Patients With Psoriatic Arthritis

In this Q&A, Gerd R. Burmester, MD, discussed the findings of his study that evaluated the exposure to ixekizumab, outcomes and medical history of patients with active psoriatic arthritis (PsA) who experienced adverse events.

Increased Risk of Aortic Regurgitation, Atrial Fibrillation in Patients With Radiographic Axial Spondyloarthritis

The European Alliance of Associations for Rheumatology (EULAR) recommends screening and early management of cardiovascular disease in patients with radiographic axial spondyloarthritis.

Cognitive Performance Significantly Lower in Patients With SLE

The cross-sectional analysis determined cognitive performance of patients with systemic lupus erythematosus was significantly lower when compared with controls in both motor speed and psychomotor speed domains.

Guselkumab Decreases Levels of Collagen-Degrading Biomarkers in Patients With PsA

“Biomarkers can be used to elucidate normal and pathological processes and to measure biological response to a therapeutic intervention,” investigators stated.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.